AURA
Aura Biosciences Inc

234
Mkt Cap
$355.62M
Volume
63,432.00
52W High
$8.16
52W Low
$4.35
PE Ratio
-2.90
AURA Fundamentals
Price
$5.61
Prev Close
$5.60
Open
$5.56
50D MA
$5.76
Beta
1.36
Avg. Volume
184,025.60
EPS (Annual)
-$1.75
P/B
2.25
Rev/Employee
$0.00
$275.80
Loading...
Loading...
News
all
press releases
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six brokerages that are currently covering the firm, MarketBeat reports. One...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Aura Biosciences (NASDAQ:AURA) Insider Sells $82,270.08 in Stock
Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) insider Los Pinos Elisabet De sold 16,928 shares of the stock in a transaction dated Tuesday, January 20th. The stock was sold at an average...
MarketBeat·19d ago
News Placeholder
Aura Biosciences (NASDAQ:AURA) Insider Los Pinos Elisabet De Sells 16,928 Shares
Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) insider Los Pinos Elisabet De sold 16,928 shares of the firm's stock in a transaction that occurred on Tuesday, January 20th. The stock was sold...
MarketBeat·20d ago
News Placeholder
Aura Biosciences, Inc. (NASDAQ:AURA) Given Consensus Rating of "Moderate Buy" by Analysts
Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) has received an average recommendation of "Moderate Buy" from the seven brokerages that are presently covering the firm, Marketbeat reports. One...
MarketBeat·29d ago
News Placeholder
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Rating of "Moderate Buy" from Analysts
Shares of Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the seven research firms that are presently covering the stock...
MarketBeat·2mo ago
News Placeholder
Frazier Life Sciences Management L.P. Makes New $31.93 Million Investment in Aura Biosciences, Inc. $AURA
Frazier Life Sciences Management L.P. acquired a new stake in Aura Biosciences, Inc. (NASDAQ:AURA - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC...
MarketBeat·2mo ago
News Placeholder
Aura Biosciences, Inc. $AURA Shares Bought by Franklin Resources Inc.
Franklin Resources Inc. raised its stake in shares of Aura Biosciences, Inc. (NASDAQ:AURA - Free Report) by 5.9% in the second quarter, according to its most recent 13F filing with the SEC. The fund...
MarketBeat·2mo ago
News Placeholder
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Recommendation of "Moderate Buy" from Brokerages
Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six ratings firms that are currently covering the stock, Marketbeat.com reports. One...
MarketBeat·3mo ago
News Placeholder
Insider Selling: Aura Biosciences (NASDAQ:AURA) Insider Sells 17,109 Shares of Stock
Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) insider Janet Jill Hopkins sold 17,109 shares of the stock in a transaction that occurred on Monday, November 17th. The shares were sold at an...
MarketBeat·3mo ago
News Placeholder
Aura Biosciences (NASDAQ:AURA) Releases Earnings Results
Aura Biosciences (NASDAQ:AURA - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.40) EPS for the quarter, beating analysts' consensus estimates of ($0.46) by $0.06...
MarketBeat·3mo ago
<
1
2
...
>

Latest AURA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.